InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,464.72
(
-0.15%
)
US TECH 100
19,223.20
(
-0.18%
)
Dow Jones
39,150.63
(
0.04%
)
Brent Oil
84.43
(
-0.68%
)
Bitcoin
64,255.18
(
-0.87%
)
Post# of 97239
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

read_this_n0w

Send PM Follow Ignore
Followers 250
Posts 14020
Boards Moderated 3
Alias Born 07/07/2006

read_this_n0w

Re: None

Wednesday, 02/29/2012 3:31:17 PM

Wednesday, February 29, 2012 3:31:17 PM

Post# of 97239
BRIEF-Amarin updates on FDA advisory committee schedule in connection with NDA for AMR101


Feb 13 (Reuters) - Amarin Corp PLC <AMRN.O>:
* Announces FDA advisory committee will not be scheduled in connection with new
drug application for AMR101
* FDA had previously assigned pdufa date of July 26 2012 for completion of its
review of the AMR101 NDA


To follow my postings on ihub use this link : Ihub person mark
Feedback is allways appreciated, as are other (annotated) picks

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up